Health Care & Life Sciences » Pharmaceuticals | Vital KSK Holdings Inc.

Vital KSK Holdings Inc. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
6,929
6,390
10,174
6,880
6,492
7,688
Depreciation, Depletion & Amortization
2,223
2,814
3,289
3,358
3,236
3,778
Other Funds
3
46
2
2
3
5,302
Funds from Operations
4,472
6,496
11,592
4,739
7,262
6,162
Changes in Working Capital
14,880
3,019
13,943
3,570
9,521
12,067
Net Operating Cash Flow
10,408
9,515
2,351
1,169
16,783
18,229
Capital Expenditures
5,927
4,358
4,229
4,909
8,233
Sale of Fixed Assets & Businesses
252
24
10
115
12
Purchase/Sale of Investments
8,084
4,528
5,264
1,258
641
Net Investing Cash Flow
2,602
13,755
1,346
6,789
8,201
Cash Dividends Paid - Total
948
911
1,004
1,463
1,128
Issuance/Reduction of Debt, Net
2,363
9,462
1,504
3,158
2,241
Net Financing Cash Flow
627
6,432
2,145
1,690
4,119
Net Change in Cash
7,179
2,192
3,150
3,930
4,463
Free Cash Flow
15,254
6,055
4,416
3,308
8,958
Net Assets from Acquisitions
-
5,246
-
-
-
Other Sources
244
353
301
373
690
Change in Capital Stock
785
2,073
365
1
-
Other Uses
51
-
-
1,110
30

About Vital KSK Holdings

View Profile
Address
Kyodo Building, 9/F
Tokyo Tokyo 103
Japan
Employees -
Website http://www.vitalksk.co.jp
Updated 07/08/2019
Vital KSK Holdings, Inc. engages in the management of its group companies which are involved in the pharmaceutical business. It operates through the Pharmaceutical Wholesale and Others segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners.